Pesquisar
Shattuck Labs Inc
STTKAdicionar à lista de desejos
6.260USD
-0.410-6.15%
Fechamento 05/15, 16:00（ET）Cotações atrasadas em 15 min
473.14MValor de mercado
PerdaP/L TTM
Mais detalhes de Shattuck Labs Inc Empresa
Shattuck Labs, Inc. is a biotechnology company. The Company is engaged in the development of treatments for inflammatory and immune-mediated diseases. Its lead product candidate, SL-325, is a monoclonal antibody that is designed to bind to death receptor 3 (DR3) and inhibit its interaction with its ligand, TL1A. TL1A is a costimulatory ligand in the tumor necrosis factor superfamily, which activates immune responses through binding a single receptor, DR3. The Company is conducting a Phase I clinical trial in healthy volunteers. In addition, the Company is also developing SL-425, a half-life extended version of SL-325. It is also developing multiple preclinical DR3-based bispecific antibodies, which are designed to inhibit both the DR3/TL1A axis and another biologically relevant target for the treatment of patients with inflammatory bowel disease.
Informações de Shattuck Labs Inc
Código da empresaSTTK
Nome da EmpresaShattuck Labs Inc
Data de listagemOct 09, 2020
CEOSchreiber (Taylor)
Número de funcionários44
Tipo de títulosOrdinary Share
Fim do ano fiscalOct 09
Endereço500 W. 5Th Street
CidadeAUSTIN
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal78701
Telefone15129004690
Sitehttps://www.shattucklabs.com/
Código da empresaSTTK
Data de listagemOct 09, 2020
CEOSchreiber (Taylor)
Executivos da empresa Shattuck Labs Inc
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Taylor Schreiber, M.D., Ph.D.
Dr. Taylor Schreiber, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
96.61K
--
Dr. Stephen Stout, Ph.D.
Dr. Stephen Stout, Ph.D.
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
80.56K
-1.20%
Dr. George S. Golumbeski, Ph.D.
Dr. George S. Golumbeski, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
54.61K
--
Dr. Neil W. Gibson ,Ph.D.
Dr. Neil W. Gibson ,Ph.D.
Independent Director
Independent Director
52.74K
--
Dr. Arundathy Nirmalini (Lini) Pandite
Dr. Arundathy Nirmalini (Lini) Pandite
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Casi Deyoung
Ms. Casi Deyoung
Chief Business Officer
Chief Business Officer
--
--
Mr. Andrew R. Neill
Mr. Andrew R. Neill
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Helen M. Boudreau
Ms. Helen M. Boudreau
Independent Director
Independent Director
--
--
Mr. Conor Richardson, CPA
Mr. Conor Richardson, CPA
Senior Director, Finance & Investor Relations
Senior Director, Finance & Investor Relations
--
--
Dr. Abhinav A. Shukla, Ph.D.
Dr. Abhinav A. Shukla, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Dr. Taylor Schreiber, M.D., Ph.D.
Dr. Taylor Schreiber, M.D., Ph.D.
Chief Executive Officer, Co-Founder, Director
Chief Executive Officer, Co-Founder, Director
96.61K
--
Dr. Stephen Stout, Ph.D.
Dr. Stephen Stout, Ph.D.
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
80.56K
-1.20%
Dr. George S. Golumbeski, Ph.D.
Dr. George S. Golumbeski, Ph.D.
Independent Chairman of the Board
Independent Chairman of the Board
54.61K
--
Dr. Neil W. Gibson ,Ph.D.
Dr. Neil W. Gibson ,Ph.D.
Independent Director
Independent Director
52.74K
--
Dr. Arundathy Nirmalini (Lini) Pandite
Dr. Arundathy Nirmalini (Lini) Pandite
Chief Medical Officer
Chief Medical Officer
--
--
Ms. Casi Deyoung
Ms. Casi Deyoung
Chief Business Officer
Chief Business Officer
--
--
Detalhamento da receita
Os dados relevantes ainda não foram divulgados pela empresa.
Os dados relevantes ainda não foram divulgados pela empresa.
Por Empresa
Por Região
Os dados relevantes ainda não foram divulgados pela empresa.
Distribuição de ações
Atualizado em: dom, 10 de mai
Atualizado em: dom, 10 de mai
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
T. Rowe Price Investment Management, Inc.
9.62%
OrbiMed Advisors, LLC
8.22%
Adage Capital Management, L.P.
8.22%
Redmile Group, LLC
7.22%
NEXTBio Capital Management LP
4.11%
Outro
62.60%
Investidores
Investidores
Proporção
T. Rowe Price Investment Management, Inc.
9.62%
OrbiMed Advisors, LLC
8.22%
Adage Capital Management, L.P.
8.22%
Redmile Group, LLC
7.22%
NEXTBio Capital Management LP
4.11%
Outro
62.60%
Tipos de investidores
Investidores
Proporção
Investment Advisor
18.05%
Investment Advisor/Hedge Fund
17.65%
Hedge Fund
16.84%
Private Equity
8.22%
Corporation
4.08%
Family Office
2.13%
Research Firm
1.79%
Individual Investor
1.18%
Pension Fund
0.03%
Outro
30.02%
Participação acionária institucional
Atualizado em: qua, 1 de abr
Atualizado em: qua, 1 de abr
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2026Q1
189
50.41M
65.78%
+9.74M
2025Q4
187
35.93M
56.78%
+4.02M
2025Q3
179
32.72M
51.71%
-1.24M
2025Q2
186
35.33M
73.76%
-6.35M
2025Q1
190
36.10M
75.45%
-5.76M
2024Q4
182
37.00M
77.49%
-7.77M
2024Q3
191
41.87M
87.75%
-1.86M
2024Q2
194
39.66M
83.35%
+16.66K
2024Q1
209
37.10M
79.60%
-1.39M
2023Q4
203
34.54M
71.04%
+5.75M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
T. Rowe Price Investment Management, Inc.
7.37M
10.3%
+6.02M
+444.29%
Jan 31, 2026
OrbiMed Advisors, LLC
6.31M
8.81%
--
--
Dec 31, 2025
Adage Capital Management, L.P.
6.31M
8.81%
--
--
Dec 31, 2025
Redmile Group, LLC
5.54M
7.74%
--
--
Dec 31, 2025
NEXTBio Capital Management LP
3.15M
4.4%
+3.15M
--
Dec 31, 2025
Houghton Capital Holdings, LLC
2.61M
3.65%
--
--
Apr 01, 2025
Prosight Capital
2.38M
3.33%
-3.07M
-56.31%
Dec 31, 2025
T. Rowe Price Associates, Inc.
1.93M
2.69%
+1.89M
+5515.57%
Dec 31, 2025
The Clark Estates Inc.
1.48M
2.06%
--
--
Dec 31, 2025
Ver Mais
ETFs Relacionados
Atualizado em: sáb, 6 de dez
Atualizado em: sáb, 6 de dez
Nome
Proporção
Texas Capital Texas Equity Index ETF
0%
iShares Russell 2000 Value ETF
0%
ProShares UltraPro Russell2000
0%
Dimensional US Core Equity 1 ETF
0%
ProShares Hedge Replication ETF
0%
iShares Morningstar Small-Cap ETF
0%
iShares Russell 2000 ETF
0%
Avantis US Small Cap Equity ETF
0%
iShares Micro-Cap ETF
0%
Texas Capital Texas Small Cap Equity Index ETF
0%
Ver Mais
Texas Capital Texas Equity Index ETF
Proporção0%
iShares Russell 2000 Value ETF
Proporção0%
ProShares UltraPro Russell2000
Proporção0%
Dimensional US Core Equity 1 ETF
Proporção0%
ProShares Hedge Replication ETF
Proporção0%
iShares Morningstar Small-Cap ETF
Proporção0%
iShares Russell 2000 ETF
Proporção0%
Avantis US Small Cap Equity ETF
Proporção0%
iShares Micro-Cap ETF
Proporção0%
Texas Capital Texas Small Cap Equity Index ETF
Proporção0%
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
Data
Data ex-dividendo
Tipo
Proporção
Sem dados
